DexCom
DXCM
$124.34
Share price
-9.91%
Change (1 day)
0.61%
Change (1 year)
Categories
DexCom (DXCM) - Net assets
Net assets on the balance sheet as of December 2023 : $2.06 B
According to DexCom's latest financial reports the company has $2.06 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
DexCom - Net assets on balance sheet (from 2005 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $2.06 B | -2.96% |
| 2022-12-31 | $2.13 B | 4.39% |
| 2021-12-31 | $2.04 B | 11.8% |
| 2020-12-31 | $1.82 B | 106.95% |
| 2019-12-31 | $0.88 B | 33.06% |
| 2018-12-31 | $0.66 B | 58.15% |
| 2017-12-31 | $0.41 B | 47.78% |
| 2016-12-31 | $0.28 B | 28.3% |
| 2015-12-31 | $0.22 B | 57.77% |
| 2014-12-31 | $0.14 B | 66.71% |
| 2013-12-31 | $84.1 M | 9.22% |
| 2012-12-31 | $77 M | -26.32% |
| 2011-12-31 | $0.10 B | 71.33% |
| 2010-12-31 | $60.99 M | -430.67% |
| 2009-12-31 | $-18.45 M | -5.25% |
| 2008-12-31 | $-19.47 M | -373.62% |
| 2007-12-31 | $7.11 M | -87.48% |
| 2006-12-31 | $56.82 M | 15.01% |
| 2005-12-31 | $49.41 M | -200.21% |
| 2004-12-31 | $-49.31 M | 51.25% |
| 2003-12-31 | $-32.61 M | |
| 2001-12-31 | $-8.93 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 3,224.66% | 🇺🇸 USA |
 Abbott Laboratories ABT | $38.82 B | 1,776.97% | 🇺🇸 USA |
 Medtronic MDT | $51.99 B | 2,413.58% | 🇮🇪 Ireland |
 Becton Dickinson BDX | $25.33 B | 1,124.64% | 🇺🇸 USA |
 Edwards Lifesciences EW | $6.71 B | 224.83% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | $0.31 B | -84.84% | 🇺🇸 USA |
 QuidelOrtho QDEL | $5.00 B | 141.99% | 🇺🇸 USA |
 West Pharmaceutical WST | $2.88 B | 39.27% | 🇺🇸 USA |